MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ebiom.2025.106064

Медицинская библиотека · EBioMedicine · 2025

Metabolic inflammation, brain age and cognitive functioning in short- and long-term clinical weight loss trials.

Maurer Lukas, Kozarzewski Leonard, Haberbosch Linus, Flöel Agnes, Haynes John-Dylan, Spranger Joachim, Mai Knut, Weygandt Martin

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Observational studies suggest that metabolic inflammation in obesity can impair brain health, but studies on beneficial effects of weight loss-induced improvements in such markers on brain health and their consequences for clinical outcomes are scarce.

METHODS

Consequently, we investigated 53 obese participants in a short-term dietary weight loss trial (up to 4 months, 137 samples; "Muscle Metabolism Study" or "MMS") and 30 in an independent long-term trial (up to 39 months, 100 samples; "Maintain"). For each participant and visit, brain health was characterised in terms of the "brain-predicted age difference" ("brain-PAD"; the difference of the age of a person predicted with machine learning from structural brain MRI minus their chronological age). Increasingly positive brain-PAD scores indicate increasingly poorer brain health. Further, we determined the HOMA index, leptin, fetuin B and CRP levels as markers collectively reflecting low-grade inflammation and impaired metabolic signalling. Finally, we evaluated the relevance of these parameters for brain-PAD and the association of brain-PAD alterations for cognition, which was measured in the MMS with neuropsychological tests.

FINDINGS: Weight loss led to improved brain-PAD scores (MMS: t = -2.02, p = 0.023, effect size partial η2 (η2p) = 0.03; Maintain: t = -7.37, p = 4.2·10-11, η2p = 0.38). According to a False Discovery Rate (FDR) method-corrected threshold (αFDR = 0.05), HOMA index (MMS: t = 2.28, pFDR = 0.024, η2p = 0.04; Maintain: t = 2.33, pFDR = 0.023, η2p = 0.08), and leptin (MMS: t = 4.43, pFDR = 4.3·10-5, η2p = 0.14; Maintain: t = 1.91, pFDR = 0.041, η2p = 0.06), showed significant positive links to brain-PAD in both trials, fetuin B did so in Maintain (t = 2.57, pFDR = 0.023, η2p = 0.11). Brain-PAD variations were associated with a neuropsychological test of psychomotor speed and visual attention (t = 2.32, pFDR = 0.022, η2p = 0.05). Application of explainable artificial intelligence methods showed that this link was parallelled by widespread brain age-related tissue alterations in white and grey matter involved in these functions.

INTERPRETATION: Analyses of two independent weight loss trials suggest that weight loss-induced improvements in metabolic-inflammatory markers have beneficial effects on brain-PAD and the latter were associated with enhancements in cognitive functioning, underscoring the potential clinical relevance of metabolic brain age regulation.

FUNDING: German Research Foundation; German Ministry for Education and Research, Berlin Institute of Health; German Centre for Cardiovascular Research; German Center for Diabetes Research.

Для цитирования: Maurer Lukas, Kozarzewski Leonard, Haberbosch Linus, Flöel Agnes, Haynes John-Dylan, Spranger Joachim, Mai Knut, Weygandt Martin. Metabolic inflammation, brain age and cognitive functioning in short- and long-term clinical weight loss trials.. EBioMedicine. 2025. DOI: 10.1016/j.ebiom.2025.106064.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.